- Diabetes Drugs Linked to Cancer
Many of the most popular prescription drugs used to treat Type 2 diabetes have been linked to serious health problems in some patients, including pancreatic cancer.
- Heartburn Drugs Linked to Kidney Disease
Proton pump inhibitors (PPIs), a class of prescription heartburn drugs, are used to reduce acid in a patient’s stomach. But many of the most popular PPIs have been linked to serious health risks — including chronic kidney disease.
- Invokana® & Invokamet®
The Type 2 diabetes drugs Invokana® and Invokamet® may increase the risk of ketoacidosis—a potentially fatal condition that is typically diagnosed among patients with Type 1 diabetes.
- Low T Heart Attacks
AndroGel® and other testosterone-boosting treatments have been shown to double the risk of cardiovascular injuries in male patients.
An FDA advisory committee concluded taking the prescription Type 2 diabetes drug Onglyza® (saxagliptin) can increase the risk of heart failure—a fatal condition.
- Taxotere® Permanent Hair Loss
Taxotere®, an injectable concentrate used during chemotherapy treatment for cancer, has been linked to permanent hair loss in female breast cancer survivors.
- Viagra® Skin Cancer
Research shows that the erectile dysfunction drug Viagra® may increase the risk of melanoma—an aggressive form of skin cancer—in male patients, regardless of their family histories of cancer, medical histories, and exposure to sunlight.
The anticoagulant drug Xarelto® has been linked to an increased risk of severe bleeding in certain types of patients.
- Zofran® Birth Defects
Approved by the U.S. Food and Drug Administration to treat nausea caused by cancer treatments or surgery, Zofran® is also sometimes prescribed to pregnant women with severe morning sickness. However, data suggests the drug may cause birth defects in children born to women who take the drug.